Jan Kalyan Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in New Delhi, Delhi, India, established in 2016.
2016 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Jan Kalyan Pharmaceuticals Private Limited

Jan Kalyan Pharmaceuticals Private Limited, a struck off private limited company, was established on 18 January 2016 in New Delhi, Delhi, India. Engaging in retailers within the trade sector, it holds CIN: U51397DL2016PTC289665. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sangeeta Kapoor (Director), Rohit Mohan Kapoor (Director). Past directors included Raghuvinder Kumar, Ishita Grotra. Its latest AGM occurred on 10 August 2021, with the balance sheet filed on 31 March 2021. It is based at E-78, Ground Floor, Kalkaji, New Delhi, Delhi, 110019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397DL2016PTC289665

  • Registration Number

    289665

  • Incorporation Date

    18 January 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 1 Month
  • Last Filing with ROC 31 Mar 2021
Company report

Jan Kalyan Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Jan Kalyan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jan Kalyan Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sangeeta Kapoor Director 20 Mar 2017 Current
Rohit Mohan Kapoor Director 20 Mar 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Apr 2017 Past
Pramod Abcsdd Director 14 Apr 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jan Kalyan Pharmaceuticals.

Jan Kalyan Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Jan Kalyan Pharmaceuticals revenue growth over time
Jan Kalyan Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jan Kalyan Pharmaceuticals?

In 2017, Jan Kalyan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Jan Kalyan Pharmaceuticals?

Unlock and access historical data on people associated with Jan Kalyan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jan Kalyan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jan Kalyan Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jan Kalyan Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Jan Kalyan Pharmaceuticals Private Limited last Annual general meeting of members was held on 10 Aug 2021 as per latest MCA records. was documented.

  • Balance Sheet

    Jan Kalyan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Sangeeta Kapoor was appointed as a Director was appointed as a Director on 20 Mar 2017 & has been associated with this company since 8 years 11 months . was completed.

  • Director Appointment

    Progress on Rohit Mohan Kapoor was appointed as a Director was appointed as a Director on 20 Mar 2017 & has been associated with this company since 8 years 11 months . was documented.

  • Company Incorporation

    Progress on Jan Kalyan Pharmaceuticals Private Limited was registered on 18 Jan 2016 with Roc Delhi & aged 10 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Jan Kalyan Pharmaceuticals Private Limited?

The CIN of Jan Kalyan Pharmaceuticals Private Limited is U51397DL2016PTC289665.

Where is Jan Kalyan Pharmaceuticals Private Limited headquartered?

Jan Kalyan Pharmaceuticals Private Limited is headquartered at E-78, Ground Floor, Kalkaji, New Delhi, Delhi, 110019.

When was Jan Kalyan Pharmaceuticals Private Limited incorporated?

Jan Kalyan Pharmaceuticals Private Limited was incorporated on 18 January 2016.

Who are the current directors of Jan Kalyan Pharmaceuticals Private Limited?

The current directors of Jan Kalyan Pharmaceuticals Private Limited are

What is the primary industry of Jan Kalyan Pharmaceuticals Private Limited?

The primary industry of Jan Kalyan Pharmaceuticals Private Limited is Trade.

Is Jan Kalyan Pharmaceuticals Private Limited a listed company?

Jan Kalyan Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Jan Kalyan Pharmaceuticals Private Limited?

The authorized capital of Jan Kalyan Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Jan Kalyan Pharmaceuticals Private Limited?

The compliance status of Jan Kalyan Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available